<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-4-0-2</article-id><article-id pub-id-type="publisher-id">3244</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Study of microbiome aberrations in patients with irritable bowel syndrome with diarrhea by next-generation sequencing&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Study of microbiome aberrations in patients with irritable bowel syndrome with diarrhea by next-generation sequencing&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Smirnova</surname><given-names>Yuliya D.</given-names></name><name xml:lang="en"><surname>Smirnova</surname><given-names>Yuliya D.</given-names></name></name-alternatives><email>dyd16@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Gryaznova</surname><given-names>Mariya V.</given-names></name><name xml:lang="en"><surname>Gryaznova</surname><given-names>Mariya V.</given-names></name></name-alternatives><email>mariya-vg@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Burakova</surname><given-names>Inna Yu.</given-names></name><name xml:lang="en"><surname>Burakova</surname><given-names>Inna Yu.</given-names></name></name-alternatives><email>vitkalovai@inbox.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Syromyatnikov</surname><given-names>Mikhail Yu.</given-names></name><name xml:lang="en"><surname>Syromyatnikov</surname><given-names>Mikhail Yu.</given-names></name></name-alternatives><email>syromyatnikov@bio.vsu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Sviridova</surname><given-names>Tatyana N.</given-names></name><name xml:lang="en"><surname>Sviridova</surname><given-names>Tatyana N.</given-names></name></name-alternatives><email>tatosha033@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Lebedeva</surname><given-names>Olga P.</given-names></name><name xml:lang="en"><surname>Lebedeva</surname><given-names>Olga P.</given-names></name></name-alternatives><email>lebedeva@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Maslov</surname><given-names>Alexander Y.</given-names></name><name xml:lang="en"><surname>Maslov</surname><given-names>Alexander Y.</given-names></name></name-alternatives><email>alex.maslov@einsteinmed.org</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Popov</surname><given-names>Vasily N.</given-names></name><name xml:lang="en"><surname>Popov</surname><given-names>Vasily N.</given-names></name></name-alternatives><email>pvn@vsuet.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/4/НР_Медицина-30-44.pdf" /><abstract xml:lang="ru"><p>Background: Irritable bowel syndrome (IBS) is a common functional disorder of the gastrointestinal tract (GIT). Despite the prevalence of this disease, our understanding of the etiology remains limited. However, there is no doubt that microbial factors play a key role in the pathophysiology of IBS. The aim of the study: To investigate the microbiological composition of the intestines of patients with IBS-D. Materials and methods: We used the next-generation sequencing (NGS) method, aimed at targeted sequencing of the hypervariable region V3 of the 16S rRNA gene, which allowed us to study in detail the changes in the microbiome composition in patients. Results: An increase in the number of members of the genera Streptococcus and Haemophilus was revealed in the group of patients with IBS-D, they are mainly represented by opportunistic pathogens and are associated with the development of IBS. At the same time, there was a decrease in bacterial genera: Ruminococcaceae NK4A214, Butyricimonas, Christensenellaceae R-7, Ruminococcaceae DTU089, Coprobacter, Enterococcus and Sciscionella compared to the healthy group. Significant results were also obtained in the correlation analysis between bacteria, showing the relationship of bacteria associated with IBS. Conclusion: Genetic analysis revealed significant differences between the groups of healthy and IBS patients in the composition of the bacterial microbiome. Our results show that the composition of the gut microbiome changes in people with IBS. Thus, this study contributes to understanding the development of IBS-D in terms of microbiome changes.</p></abstract><trans-abstract xml:lang="en"><p>Background: Irritable bowel syndrome (IBS) is a common functional disorder of the gastrointestinal tract (GIT). Despite the prevalence of this disease, our understanding of the etiology remains limited. However, there is no doubt that microbial factors play a key role in the pathophysiology of IBS. The aim of the study: To investigate the microbiological composition of the intestines of patients with IBS-D. Materials and methods: We used the next-generation sequencing (NGS) method, aimed at targeted sequencing of the hypervariable region V3 of the 16S rRNA gene, which allowed us to study in detail the changes in the microbiome composition in patients. Results: An increase in the number of members of the genera Streptococcus and Haemophilus was revealed in the group of patients with IBS-D, they are mainly represented by opportunistic pathogens and are associated with the development of IBS. At the same time, there was a decrease in bacterial genera: Ruminococcaceae NK4A214, Butyricimonas, Christensenellaceae R-7, Ruminococcaceae DTU089, Coprobacter, Enterococcus and Sciscionella compared to the healthy group. Significant results were also obtained in the correlation analysis between bacteria, showing the relationship of bacteria associated with IBS. Conclusion: Genetic analysis revealed significant differences between the groups of healthy and IBS patients in the composition of the bacterial microbiome. Our results show that the composition of the gut microbiome changes in people with IBS. Thus, this study contributes to understanding the development of IBS-D in terms of microbiome changes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>microbiome</kwd><kwd>16S rRNA</kwd><kwd>sequencing</kwd><kwd>irritable bowel syndrome</kwd></kwd-group><kwd-group xml:lang="en"><kwd>microbiome</kwd><kwd>16S rRNA</kwd><kwd>sequencing</kwd><kwd>irritable bowel syndrome</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Raskov H, Burcharth J, Pommergaard HC, et al. Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes. 2016;7(5):365-383. DOI: https://doi.org/10.1080/19490976.2016.1218585</mixed-citation></ref><ref id="B2"><mixed-citation>Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World Journal of Gastroenterology. 2014;20(22):6759-6773. DOI: https://doi.org/10.3748/wjg.v20.i22.6759</mixed-citation></ref><ref id="B3"><mixed-citation>Defrees DN, Bailey J. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Primary Care - Clinics in Office Practice. 2017;44(4):655-671. DOI: https://doi.org/10.1016/j.pop.2017.07.009</mixed-citation></ref><ref id="B4"><mixed-citation>Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, et al. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2018;162(1):1-9. DOI: https://doi.org/10.5507/bp.2017.057</mixed-citation></ref><ref id="B5"><mixed-citation>Zhu X, Hong G, Li Y, et al. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Microbiology spectrum. 2021;9(3):e0125521. DOI: https://doi.org/10.1128/Spectrum.01255-21</mixed-citation></ref><ref id="B6"><mixed-citation>Holten KB, Wetherington A, Bankston L. Diagnosing the Patient with Abdominal Pain and Altered Bowel Habits: Is it Irritable Bowel Syndrome? American Family Physician. 2003;67(10):2157-2162.</mixed-citation></ref><ref id="B7"><mixed-citation>Altomare A, Di Rosa C, Imperia E, et al. Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms. Nutrients. 2021;13(5):1506. DOI: https://doi.org/10.3390/nu13051506</mixed-citation></ref><ref id="B8"><mixed-citation>Zhan K, Zheng H, Li J, et al. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. BioMed Research International. 2020;2020:3828249. DOI: https://doi.org/10.1155/2020/3828249</mixed-citation></ref><ref id="B9"><mixed-citation>Lacy BE, Chey WD, Cash BD, et al. Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. American Journal of Gastroenterology. 2017;112(6):924-932. DOI: https://doi.org/10.1038/ajg.2017.72</mixed-citation></ref><ref id="B10"><mixed-citation>Kim J, Cho K, Kim JS, et al. Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial. Food Science and Biotechnology. 2019;29:837-844. DOI: https://doi.org/10.1007/s10068-019-00717-2</mixed-citation></ref><ref id="B11"><mixed-citation>Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the microbiome. Journal of Clinical Investigation. 2022;132(7):e154944. DOI: https://doi.org/10.1172/JCI154944</mixed-citation></ref><ref id="B12"><mixed-citation>Krzyściak W, Pluskwa KK, Jurczak A, et al. The pathogenicity of the Streptococcus genus. European Journal of Clinical Microbiology and Infectious Diseases. 2013;32:1361-1376. DOI: https://doi.org/10.1007/s10096-013-1914-9</mixed-citation></ref><ref id="B13"><mixed-citation>Mars RAT, Yang Y, Ward T, et al. Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome. Cell. 2020;182(6):1460-1473. DOI: https://doi.org/10.1016/j.cell.2020.08.007</mixed-citation></ref><ref id="B14"><mixed-citation>Kassinen A, Krogius-Kurikka L, M&amp;auml;kivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133(1):24-33. DOI: https://doi.org/10.1053/j.gastro.2007.04.005</mixed-citation></ref><ref id="B15"><mixed-citation>Rajilić-Stojanović M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792-1801. DOI: https://doi.org/10.1053/j.gastro.2011.07.043</mixed-citation></ref><ref id="B16"><mixed-citation>Xiao L, Liu Q, Luo M, et al. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology. 2021;11:729346. DOI: https://doi.org/10.3389/fcimb.2021.729346</mixed-citation></ref><ref id="B17"><mixed-citation>Pozuelo M, Panda S, Santiago A, et al. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Scientific Reports. 2015;5:12693. DOI: https://doi.org/10.1038/srep12693</mixed-citation></ref><ref id="B18"><mixed-citation>Kerr GRD, Forbes KJ, Williams A, et al. An analysis of the diversity of Haemophilus parainfluenzae in the adult human respiratory tract by genomic DNA fingerprinting. Epidemiology and Infection. 1993;111(1):89-98. DOI: https://doi.org/10.1017/s0950268800056715</mixed-citation></ref><ref id="B19"><mixed-citation>Fink DL, Geme JW. The Genus. The Prokaryotes. 2006;1034-1061.</mixed-citation></ref><ref id="B20"><mixed-citation>Saulnier DM, Riehle K, Mistretta TA, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1782-1791. DOI: https://doi.org/10.1053/j.gastro.2011.06.072</mixed-citation></ref><ref id="B21"><mixed-citation>Mokha JS, Hyams JS. Irritable bowel syndrome. Pediatric Neurogastroenterology: Gastrointestinal Motility and Functional Disorders in Children: Second Edition. 2016;399-410.</mixed-citation></ref><ref id="B22"><mixed-citation>Liu Y, Yuan X, Li L, et al. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome. Clinical and Translational Gastroenterology. 2020;11(3):e00146. DOI: https://doi.org/10.14309/ctg.0000000000000146</mixed-citation></ref><ref id="B23"><mixed-citation>Chen Z, Radjabzadeh D, Chen L, et al. Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity: A Microbiome-Wide Analysis From Population Studies. JAMA network open. 2021;4(7):e2118811. DOI: https://doi.org/10.1001/jamanetworkopen.2021.18811</mixed-citation></ref><ref id="B24"><mixed-citation>Fredericks E, Theunissen R, Roux S. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome. Turkish Journal of Gastroenterology. 2020;31(12):840-847. DOI: https://doi.org/10.5152/tjg.2020.19856</mixed-citation></ref><ref id="B25"><mixed-citation>Liu Y, Yu X, Yu L, Tian F, Zhao J, Zhang H, et al. Lactobacillus plantarum CCFM8610 Alleviates Irritable Bowel Syndrome and Prevents Gut Microbiota Dysbiosis: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial. Engineering 2021;7:376-385. DOI:&amp;nbsp; https://doi.org/10.1016/j.eng.2020.06.026</mixed-citation></ref><ref id="B26"><mixed-citation>Sakamoto M, Tanaka Y, Benno Y, et al. Butyricimonas faecihominis sp. nov. and Butyricimonas paravirosa sp. nov., isolated from human faeces, and emended description of the genus Butyricimonas. International Journal of Systematic and Evolutionary Microbiology. 2014;64(Pt_9):2992-2997. DOI: https://doi.org/10.1099/ijs.0.065318-0</mixed-citation></ref><ref id="B27"><mixed-citation>Lee H, Lee Y, Kim J, et al. Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice. Gut Microbes. 2018;9(2):155-165. DOI: https://doi.org/10.1080/19490976.2017.1405209</mixed-citation></ref><ref id="B28"><mixed-citation>Kim J, Lee H, An J, et al. Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia. Frontiers in Microbiology. 2019;10:1947. DOI: https://doi.org/10.3389/fmicb.2019.01947</mixed-citation></ref><ref id="B29"><mixed-citation>Simr&amp;eacute;n M, Wold A, Adlerberth I, et al. inventors. Use of butyricimonas and/or oxalobacter for treating irritable bowel syndrome. Patent WO/2018/046485. 2018 Mar 15.</mixed-citation></ref><ref id="B30"><mixed-citation>Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biology. 2019;17(1):83. DOI: https://doi.org/10.1186/s12915-019-0699-4</mixed-citation></ref><ref id="B31"><mixed-citation>Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell. 2014;159(4):789-799. DOI: https://doi.org/10.1016/j.cell.2014.09.053</mixed-citation></ref><ref id="B32"><mixed-citation>Mancabelli L, Milani C, Lugli GA, et al. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiology Ecology. 2017;93(12):153. DOI: https://doi.org/10.1093/femsec/fix153</mixed-citation></ref><ref id="B33"><mixed-citation>Hollister EB, Cain KC, Shulman RJ, et al. Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 2020;54(2):175-183. DOI: https://doi.org/10.1097/MCG.0000000000001107</mixed-citation></ref><ref id="B34"><mixed-citation>Tigchelaar EF, Bonder MJ, Jankipersadsing SA, et al. Gut microbiota composition associated with stool consistency. Gut. 2016;65:540-542. DOI: http://dx.doi.org/10.1136/gutjnl-2015-310328</mixed-citation></ref><ref id="B35"><mixed-citation>Jalanka J, Major G, Murray K, et al. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. International Journal of Molecular Sciences. 2019;20(2):433. DOI: https://doi.org/10.3390/ijms20020433</mixed-citation></ref><ref id="B36"><mixed-citation>Lo Presti A, Zorzi F, Del Chierico F, et al. Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease. Frontiers in Microbiology. 2019;10:1655. DOI: https://doi.org/10.3389/fmicb.2019.01655</mixed-citation></ref><ref id="B37"><mixed-citation>Chen O, Sudakaran S, Blonquist T, et al. Effect of arabinogalactan on the gut microbiome: A randomized, double-blind, placebo-controlled, crossover trial in healthy adults. Nutrition. 2021;90:111273. DOI: https://doi.org/10.1016/j.nut.2021.111273</mixed-citation></ref><ref id="B38"><mixed-citation>Chatterjee S, Park S, Low K, et al. The degree of breath methane production in IBS correlates with the severity of constipation. American Journal of Gastroenterology. 2007;102(4):837-841. DOI: https://doi.org/10.1111/j.1572-0241.2007.01072.x</mixed-citation></ref><ref id="B39"><mixed-citation>Chaplin AV, Efimov BA, Khokhlova EV, et al. Draft Genome Sequence of Coprobacter fastidiosus NSB1T. Genome Announcements. 2014;2(2):e00122-14. DOI: https://doi.org/10.1128/genomea.00122-14</mixed-citation></ref><ref id="B40"><mixed-citation>Biasato I, Ferrocino I, Grego E, et al. Gut Microbiota and Mucin Composition in Female Broiler Chickens Fed Diets including Yellow Mealworm (Tenebrio molitor, L.). Animals. 2019;9(5):213. DOI: https://doi.org/10.3390/ani9050213</mixed-citation></ref><ref id="B41"><mixed-citation>Chen YJ, Wu H, Wu SD, et al. Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation. Journal of Gastroenterology and Hepatology. 2018;33(11):1844-1852. DOI: https://doi.org/10.1111/jgh.14281</mixed-citation></ref><ref id="B42"><mixed-citation>Zhuang X, Xiong L, Li L, et al. Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology. 2017;32(1):28-38. DOI: https://doi.org/10.1111/jgh.13471</mixed-citation></ref><ref id="B43"><mixed-citation>Tian XP, Tang SK, Dong JD, et al. Sciscionella marina gen. nov., sp. nov., a marine actinomycete isolated from a sediment in the northern South China Sea. International Journal of Systematic and Evolutionary Microbiology. 2009;59(5):222-228. DOI: https://doi.org/10.1099/ijs.0.005231-0</mixed-citation></ref><ref id="B44"><mixed-citation>Sinha M, Shivaprakash MR, Chakrabarti A, et al. Bacteraemia caused by Sciscionella marina in a lymphoma patient: phenotypically mimicking Nocardia. Journal of Medical Microbiology. 2013;62(6):929-931. DOI: https://doi.org/10.1099/jmm.0.053561-0</mixed-citation></ref><ref id="B45"><mixed-citation>S&amp;aacute;ez-Nieto JA, Carrasco G, Pino SD, et al. Identification and antimicrobial susceptibility of Streptomyces and other unusual Actinobacteria clinical isolates in Spain. New Microbes and New Infections. 2021;44:100946. DOI: https://doi.org/10.1016/j.nmni.2021.100946</mixed-citation></ref><ref id="B46"><mixed-citation>Teyssier C, Marchandin H, De Buochberg MS, et al. Atypical 16S rRNA gene copies in Ochrobactrum intermedium strains reveal a large genomic rearrangement by recombination between rrn copies. Journal of Bacteriology. 2003;185(9):2901-2909. DOI: https://doi.org/10.1128/JB.185.9.2901-2909.2003</mixed-citation></ref><ref id="B47"><mixed-citation>Metcalf JL, Wegener Parfrey L, Gonzalez A, et al. A microbial clock provides an accurate estimate of the postmortem interval in a mouse model system. eLife. 2013;2:e01104. DOI: https://doi.org/10.7554/eLife.01104</mixed-citation></ref><ref id="B48"><mixed-citation>Priest A. Antibiotic resistant bacteria in water environments in Louisville [dissertation]. Kentucky. College of Arts &amp;amp; Sciences Senior Honors Theses; 2018.</mixed-citation></ref><ref id="B49"><mixed-citation>Teyssier C, Marchandin H, Jean-Pierre H, et al. Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp. Journal of Medical Microbiology. 2005;54(10):945-953. DOI: https://doi.org/10.1099/jmm.0.46116-0</mixed-citation></ref><ref id="B50"><mixed-citation>Mahlen SD, Clarridge JE. Site and clinical significance of Alloscardovia omnicolens and Bifidobacterium species isolated in the clinical laboratory. Journal of Clinical Microbiology. 2009;47(10):3289-3293. DOI: https://doi.org/10.1128/JCM.00555-09</mixed-citation></ref><ref id="B51"><mixed-citation>Naidoo CC, Nyawo GR, Sulaiman I, et al. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis. eBioMedicine. 2021;67:103374. DOI: https://doi.org/10.1016/j.ebiom.2021.103374</mixed-citation></ref><ref id="B52"><mixed-citation>De Seta F, Campisciano G, Zanotta N, et al. The Vaginal Community State Types Microbiome-Immune Network as Key Factor for Bacterial Vaginosis and Aerobic Vaginitis. Frontiers in Microbiology. 2019;10:2451. DOI: https://doi.org/10.3389/fmicb.2019.02451</mixed-citation></ref><ref id="B53"><mixed-citation>Kingkaw A, Nakphaichit M, Suratannon N, et al. Analysis of the infant gut microbiome reveals metabolic functional roles associated with healthy infants and infants with atopic dermatitis using metaproteomics. PeerJ. 2020;8:e9988. DOI: https://doi.org/10.7717/peerj.9988</mixed-citation></ref><ref id="B54"><mixed-citation>Dutta D, Lim SH. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomarker Research. 2020;8:31. DOI: https://doi.org/10.1186/s40364-020-00211-6</mixed-citation></ref><ref id="B55"><mixed-citation>Flores-F&amp;eacute;lix JD, Silva LR, Rivera LP, et al. Plants Probiotics as a Tool to Produce Highly Functional Fruits: The Case of Phyllobacterium and Vitamin C in Strawberries. PLoS ONE. 2015;10(4):e0122281. DOI: https://doi.org/10.1371/journal.pone.0122281</mixed-citation></ref><ref id="B56"><mixed-citation>Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al.Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67:226-236. DOI: http://dx.doi.org/10.1136/gutjnl-2017-314205</mixed-citation></ref><ref id="B57"><mixed-citation>Boutin S, Graeber SY, Weitnauer M, et al. Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis. PLoS ONE. 2015;10(1):e0116029. DOI: https://doi.org/10.1371/journal.pone.0116029</mixed-citation></ref><ref id="B58"><mixed-citation>Liatsos C, Papaefthymiou A, Kyriakos N, et al. Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle. World Journal of Gastrointestinal Oncology. 2022;14(5):959-972. DOI: https://doi.org/10.4251/wjgo.v14.i5.959</mixed-citation></ref><ref id="B59"><mixed-citation>Ramakrishnan VR, Hauser LJ, Frank DN. The sinonasal bacterial microbiome in health and disease. Current Opinion in Otolaryngology and Head and Neck Surgery. 2016;24(1):20-25. DOI: https://doi.org/10.1097/MOO.0000000000000221</mixed-citation></ref><ref id="B60"><mixed-citation>Weon HY, Anandham R, Tamura T, et al. Leucobacter denitrificans sp. nov., isolated from cow dung. Journal of Microbiology. 2012;50:161-165. DOI: https://doi.org/10.1007/s12275-012-1324-1</mixed-citation></ref><ref id="B61"><mixed-citation>Yu D, Meng X, de Vos WM, et al. Implications of Gut Microbiota in Complex Human Diseases. International Journal of Molecular Sciences. 2021;22(23):12661. DOI: https://doi.org/10.3390/ijms222312661</mixed-citation></ref><ref id="B62"><mixed-citation>Kulinich A, Wang Q, Duan XC, et al. Biochemical characterization of the endo-&amp;alpha;-N-acetylgalactosaminidase pool of the human gut symbiont Tyzzerella nexilis. Carbohydrate Research. 2020;490:107962. DOI: https://doi.org/10.1016/j.carres.2020.107962</mixed-citation></ref><ref id="B63"><mixed-citation>Daniel N, Choi B, Houde V, et al. Dietary Proteins Relevant to Human Consumption Impact the Development of Obesity and Type 2 Diabetes in Association with Major Changes in the Gut Microbiota in a Mouse Model (OR27-03-19). Current Developments in Nutrition. 2019;3(1):nzz046.OR27-03-19. DOI: https://doi.org/10.1093/cdn/nzz046.OR27-03-19</mixed-citation></ref><ref id="B64"><mixed-citation>Wang H, Wei CX, Min L, et al. Good or bad: gut bacteria in human health and diseases. Biotechnology and Biotechnological Equipment. 2018;32(5):1075-1080. DOI: https://doi.org/10.1080/13102818.2018.1481350</mixed-citation></ref><ref id="B65"><mixed-citation>Gryaznova MV, Solodskikh SA, Panevina AV, et al. Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia. Heliyon. 2021;7(3):e06432. DOI: https://doi.org/10.1016/j.heliyon.2021.e06432</mixed-citation></ref><ref id="B66"><mixed-citation>Ricaboni D, Mailhe M, Vitton V, et al. &amp;ldquo;Negativibacillus massiliensis&amp;rdquo; gen. nov., sp. nov., isolated from human left colon. New Microbes and New Infections. 2017;17:36-38. DOI: https://doi.org/10.1016/j.nmni.2016.11.002</mixed-citation></ref><ref id="B67"><mixed-citation>Louis P, Young P, Holtrop G, et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environmental Microbiology. 2010;12(2):304-314. DOI: https://doi.org/10.1111/j.1462-2920.2009.02066.x</mixed-citation></ref><ref id="B68"><mixed-citation>Thompson RS, Gaffney M, Hopkins S, et al. Ruminiclostridium 5, Parabacteroides distasonis, and bile acid profile are modulated by prebiotic diet and associate with facilitated sleep/clock realignment after chronic disruption of rhythms. Brain, Behavior, and Immunity. 2021;97:150-166. DOI: https://doi.org/10.1016/j.bbi.2021.07.006</mixed-citation></ref><ref id="B69"><mixed-citation>Yang J, Li Y, Wen Z, et al. Oscillospira - a candidate for the next-generation probiotics. Gut Microbes. 2021;13(1):1987783. DOI: https://doi.org/10.1080/19490976.2021.1987783</mixed-citation></ref><ref id="B70"><mixed-citation>Ma Q, Li Y, Wang J, et al. Investigation of gut microbiome changes in type 1 diabetic mellitus rats based on high-throughput sequencing. Biomedicine and Pharmacotherapy. 2020;124:109873. DOI: https://doi.org/10.1016/j.biopha.2020.109873</mixed-citation></ref><ref id="B71"><mixed-citation>Koo SH, Chu CW, Khoo JJC, et al. A pilot study to examine the association between human gut microbiota and the host&amp;rsquo;s central obesity. JGH Open. 2029;3(6):480-487. DOI: https://doi.org/10.1002/jgh3.12184</mixed-citation></ref><ref id="B72"><mixed-citation>Morinaga K, Kusada H, Watanabe M, et al. Complete Genome Sequence of Anaerostipes caccae Strain L1-92T, a Butyrate-Producing Bacterium Isolated from Human Feces. Microbiology Resource Announcements. 2021;10(16):e00056-21. DOI: https://doi.org/10.1128/mra.00056-21</mixed-citation></ref></ref-list></back></article>